Table 1.
Summary of clinical demographics for patients with resected metastatic squamous cell carcinomas to the brain.
| patient characteristic | lung (n=25) | head & neck (n=7) | cervix (n=3) | esophagus (n=1) | thyroid (n=1) | prostate (n=1) |
|---|---|---|---|---|---|---|
| Gender | ||||||
| Male (%) | 11 (44) | 7 (100) | 0 (0) | 1 (100) | 0 (0) | 1 (100) |
| Female (%) | 14 (56) | 0 (0) | 3 (100) | 0 (0) | 1 (100) | 0 (0) |
| Race | ||||||
| Caucasian (%) | 18 (72) | 5(63) | 2 (67) | 0 (0) | 1 (100) | 1 (100) |
| AA (%) | 5 (20) | 1 (25) | 1 (33) | 1 (100) | 0 (0) | 0 (0) |
| other (%) | 2 (8) | 1 (13) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Age (years) | ||||||
| mean | 60 | 59 | 44 | 76 | 64 | 55 |
| range | 33–78 | 42–65 | 38–78 | - | - | - |
| # of brain mets | ||||||
| mean | 1 | 2 | 1 | 1 | 1 | 1 |
| range | 1–3 | 1–9 | - | - | - | - |
| Brain met free survival | ||||||
| average | 21 | 36 | 50 | 11 | 7 | 110 |
| range | 0–96 | 8–57 | - | - | - | - |
AA, African American; met, metastasis; #, number)